Overview

A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults

Status:
Completed

Trial end date:
2017-05-01

Target enrollment:

Participant gender:

Summary

This is a single-center, prospective, open-label, outpatient pilot study evaluating the efficacy and tolerability of oxybutynin gel for axillary hyperhidrosis.

Phase:

N/A

Details

Lead Sponsor:

University of Colorado, Denver

Collaborator:

Society for Pediatric Dermatology

Treatments:

Mandelic Acids
Oxybutynin